There are already some companies dedicated to bringing ribozymes from the laboratory to the commercial world, with
potential applications as sensitive sensors of biowarfare germs or as
medical diagnostic
tests.
The Institute actively seeks gifts of all sizes to support promising «high - risk» concepts with
potential for «high payoff»
medical application, but which are not yet sufficiently developed and
tested to qualify for federal or foundation grant support.